L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO

F. Mazzotta; F. Albertoni; N. Petrosillo; G. Visco; G. Manzillo; L. Alba; P. Amoroso; E. Anzalone; E. Boumis; A. Brogi; G. Cassola; S. Corradini; G. D'Alessandro; P. D'Aniello; B. Del Mastro; V. Di Nardo; R. Francavilla; L. Fruttaldo; G. Guazzotti

L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO

Translated title of the contribution: Interferon treatment of anti-HCV chronic hepatitis: A multicentric study

F. Mazzotta, F. Albertoni, N. Petrosillo, G. Visco, G. Manzillo, L. Alba, P. Amoroso, E. Anzalone, E. Boumis, A. Brogi, G. Cassola, S. Corradini, G. D'Alessandro, P. D'Aniello, B. Del Mastro, V. Di Nardo, R. Francavilla, L. Fruttaldo, G. Guazzotti

Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani

Research output: Contribution to journal › Article › peer-review

Abstract

287 patients affected by HCV Chronic Hepatitis (C.H.) were examined in a multicentric retrospective study, sponsored by AMOI, about Interferon treatment. In 179 out of 287 (62.5%) histological diagnosis was C.A.H. Types of IFN more frequent used was recombinant IFNs (3 million three times a week for six months). We could consider 242 patients: 25 (10.7%) interrupted therapy before six months and 87 (36%) showed normal value of ALT at the end of the treatment. A second biopsy was performed in 25%, in these patients we observed 33% of them with improvements and 57% without variation.

Translated title of the contribution	Interferon treatment of anti-HCV chronic hepatitis: A multicentric study
Original language	Italian
Pages (from-to)	956-959
Number of pages	4
Journal	Giornale di Malattie Infettive e Parassitarie
Volume	44
Issue number	12
Publication status	Published - 1992

ASJC Scopus subject areas

Parasitology

Cite this

Mazzotta, F., Albertoni, F., Petrosillo, N., Visco, G., Manzillo, G., Alba, L., Amoroso, P., Anzalone, E., Boumis, E., Brogi, A., Cassola, G., Corradini, S., D'Alessandro, G., D'Aniello, P., Del Mastro, B., Di Nardo, V., Francavilla, R., Fruttaldo, L., & Guazzotti, G. (1992). L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO. Giornale di Malattie Infettive e Parassitarie, 44(12), 956-959.

L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA : RISULTATI DI UNO STUDIO MULTICENTRICO. / Mazzotta, F.; Albertoni, F.; Petrosillo, N.; Visco, G.; Manzillo, G.; Alba, L.; Amoroso, P.; Anzalone, E.; Boumis, E.; Brogi, A.; Cassola, G.; Corradini, S.; D'Alessandro, G.; D'Aniello, P.; Del Mastro, B.; Di Nardo, V.; Francavilla, R.; Fruttaldo, L.; Guazzotti, G.

In: Giornale di Malattie Infettive e Parassitarie, Vol. 44, No. 12, 1992, p. 956-959.

Research output: Contribution to journal › Article › peer-review

Mazzotta, F, Albertoni, F, Petrosillo, N, Visco, G, Manzillo, G, Alba, L, Amoroso, P, Anzalone, E, Boumis, E, Brogi, A, Cassola, G, Corradini, S, D'Alessandro, G, D'Aniello, P, Del Mastro, B, Di Nardo, V, Francavilla, R, Fruttaldo, L & Guazzotti, G 1992, 'L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO', Giornale di Malattie Infettive e Parassitarie, vol. 44, no. 12, pp. 956-959.

Mazzotta, F. ; Albertoni, F. ; Petrosillo, N. ; Visco, G. ; Manzillo, G. ; Alba, L. ; Amoroso, P. ; Anzalone, E. ; Boumis, E. ; Brogi, A. ; Cassola, G. ; Corradini, S. ; D'Alessandro, G. ; D'Aniello, P. ; Del Mastro, B. ; Di Nardo, V. ; Francavilla, R. ; Fruttaldo, L. ; Guazzotti, G. / L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA : RISULTATI DI UNO STUDIO MULTICENTRICO. In: Giornale di Malattie Infettive e Parassitarie. 1992 ; Vol. 44, No. 12. pp. 956-959.

@article{5a26f518d71d437a92e422994c591e1a,

title = "L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO",

abstract = "287 patients affected by HCV Chronic Hepatitis (C.H.) were examined in a multicentric retrospective study, sponsored by AMOI, about Interferon treatment. In 179 out of 287 (62.5%) histological diagnosis was C.A.H. Types of IFN more frequent used was recombinant IFNs (3 million three times a week for six months). We could consider 242 patients: 25 (10.7%) interrupted therapy before six months and 87 (36%) showed normal value of ALT at the end of the treatment. A second biopsy was performed in 25%, in these patients we observed 33% of them with improvements and 57% without variation.",

author = "F. Mazzotta and F. Albertoni and N. Petrosillo and G. Visco and G. Manzillo and L. Alba and P. Amoroso and E. Anzalone and E. Boumis and A. Brogi and G. Cassola and S. Corradini and G. D'Alessandro and P. D'Aniello and {Del Mastro}, B. and {Di Nardo}, V. and R. Francavilla and L. Fruttaldo and G. Guazzotti",

year = "1992",

language = "Italian",

volume = "44",

pages = "956--959",

journal = "Giornale di Malattie Infettive e Parassitarie",

issn = "0017-0321",

publisher = "U T E T SpA",

number = "12",

}

TY - JOUR

T1 - L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA

T2 - RISULTATI DI UNO STUDIO MULTICENTRICO

AU - Mazzotta, F.

AU - Albertoni, F.

AU - Petrosillo, N.

AU - Visco, G.

AU - Manzillo, G.

AU - Alba, L.

AU - Amoroso, P.

AU - Anzalone, E.

AU - Boumis, E.

AU - Brogi, A.

AU - Cassola, G.

AU - Corradini, S.

AU - D'Alessandro, G.

AU - D'Aniello, P.

AU - Del Mastro, B.

AU - Di Nardo, V.

AU - Francavilla, R.

AU - Fruttaldo, L.

AU - Guazzotti, G.

PY - 1992

Y1 - 1992

N2 - 287 patients affected by HCV Chronic Hepatitis (C.H.) were examined in a multicentric retrospective study, sponsored by AMOI, about Interferon treatment. In 179 out of 287 (62.5%) histological diagnosis was C.A.H. Types of IFN more frequent used was recombinant IFNs (3 million three times a week for six months). We could consider 242 patients: 25 (10.7%) interrupted therapy before six months and 87 (36%) showed normal value of ALT at the end of the treatment. A second biopsy was performed in 25%, in these patients we observed 33% of them with improvements and 57% without variation.

AB - 287 patients affected by HCV Chronic Hepatitis (C.H.) were examined in a multicentric retrospective study, sponsored by AMOI, about Interferon treatment. In 179 out of 287 (62.5%) histological diagnosis was C.A.H. Types of IFN more frequent used was recombinant IFNs (3 million three times a week for six months). We could consider 242 patients: 25 (10.7%) interrupted therapy before six months and 87 (36%) showed normal value of ALT at the end of the treatment. A second biopsy was performed in 25%, in these patients we observed 33% of them with improvements and 57% without variation.

UR - http://www.scopus.com/inward/record.url?scp=0027000083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027000083&partnerID=8YFLogxK

M3 - Articolo

AN - SCOPUS:0027000083

VL - 44

SP - 956

EP - 959

JO - Giornale di Malattie Infettive e Parassitarie

JF - Giornale di Malattie Infettive e Parassitarie

SN - 0017-0321

IS - 12

ER -

L'INTERFERONE NELL'EPATITE CRONICA ANTI-HCV POSITIVA: RISULTATI DI UNO STUDIO MULTICENTRICO

Abstract

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this